Thyroid Eye Disease Market Report: Trends, Forecast and Competitive Analysis to 2030

Thyroid Eye Disease Trends and Forecast

The future of the global thyroid eye disease market looks promising with opportunities in the hospital and clinic markets. The global thyroid eye disease market is expected to reach an estimated $1.40 billion by 2030 with a CAGR of 8.1% from 2024 to 2030. The major drivers for this market are the growing incidence autoimmune disease treatment, increasing number of patient compliance for treatment, and improved healthcare settings.

A more than 150-page report is developed to help in your business decisions.

Thyroid Eye Disease by Segment

The study includes a forecast for the global thyroid eye disease by treatment type, route of administration, product, end use industry, and region.

Thyroid Eye Disease Market by Treatment Type [Shipment Analysis by Value from 2018 to 2030]:

• Corticosteroids
• Vitamins
• Monoclonal Antibody
• Others

Thyroid Eye Disease Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:

• Oral
• Topical
• Parenteral

Thyroid Eye Disease Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Tablet
• Capsule
• Ointment
• Solution

Thyroid Eye Disease Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Clinics
• Others

Thyroid Eye Disease Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Thyroid Eye Disease Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies thyroid eye disease companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the thyroid eye disease companies profiled in this report include-

• Abbvie
• Novartis International
• Teva Pharmaceutical Industries
• Pfizer
• Sanofi S.A.
• Merck
• Abbot Laboratories
• Horizon Therapeutics
• Johnson & Johnson
• GE Healthcare

Thyroid Eye Disease Market Insights

• Lucintel forecasts that monoclonal antibody is expected to witness highest growth over the forecast period.

• Within this market, hospitals will remain the largest segment.

• APAC is expected to witness highest growth over the forecast period due to increasing healthcare expenditure, rising number of diseases, and rising investments by major players in the region.

Features of the Global Thyroid Eye Disease Market

• Market Size Estimates: Thyroid Eye Disease Market size estimation in terms of value ($B).

• Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

• Segmentation Analysis: Thyroid Eye Disease Market by various segments, such as by treatment type, route of administration, product, end use industry and region in terms of($B).

• Regional Analysis: Thyroid Eye Disease Market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

• Growth Opportunities: Analysis of growth opportunities in different treatment types, route of administrations, products, end use industries, and region.s for the thyroid eye disease market.

• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the thyroid eye disease market.

• Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the thyroid eye disease market size?

Answer: The global thyroid eye disease market is expected to reach an estimated $1.40 billion by 2030.

Q.2. What is the growth forecast for thyroid eye disease market?

Answer: The global thyroid eye disease market is expected to grow with a CAGR of 8.1% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the thyroid eye disease market?

Answer: The major drivers for this market are the growing incidence autoimmune disease treatment, increasing number of patient compliance for treatment, and improved healthcare settings.

Q.4. What are the major segments for thyroid eye disease market?

Answer: The future of the thyroid eye disease market looks promising with opportunities in the hospital and clinic markets.

Q.5. Who are the key thyroid eye disease market companies?

Answer: Some of the key thyroid eye disease companies are as follows:

• AbbVie
• Novartis International
• Teva Pharmaceutical Industries
• Pfizer
• Sanofi S.A.
• Merck
• Abbot Laboratories
• Horizon Therapeutics
• Johnson & Johnson
• GE Healthcare

Q.6. Which thyroid eye disease market segment will be the largest in future?

Answer: Lucintel forecasts that monoclonal antibody is expected to witness highest growth over the forecast period.

Q.7. In thyroid eye disease market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to increasing healthcare expenditure, rising number of diseases, and rising investments by major players in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the thyroid eye disease market by treatment type (corticosteroids, vitamins, monoclonal antibody, and others), route of administration (oral, topical, and parenteral), product (tablet, capsule, ointment, and solution), end use industry (hospitals, clinics, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?